category.build.title

KIR-CAR T Cells Signal a New Era for Solid Tumor Immunotherapy

First-in-human data for KIR-CAR therapy show encouraging safety and early efficacy in ovarian cancer, mesothelioma, and cholangiocarcinoma — a milestone for cell therapy in solid tumors.